Siemens Healthcare redefines Magnetic Resonance (MR) in Oncology with Tim (Total imaging matrix) technology at the 94th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) from November 30 to December 5 at McCormick Place (Booth #922, East Building/Lakeside Center, Hall D) in Chicago. Siemens offers comprehensive and state-of-the art solutions for Oncology.
MR's role in Oncology MR plays a central role in Oncology for tumour characterization, staging, pre-surgical planning, therapy monitoring, and follow-up syngo TimCT Oncology joins Siemens' comprehensive Oncology Solutions and offers continuous table movement for extended Field of View (FoV) imaging and comprehensive staging for increased workflow. For example, a pelvic exam can be completed in as little as 20 minutes. syngo TimCT Oncology reduces the need for rescheduling multiple exams on other modalities by offering one complete exam on one system. Men's Health In 2007, nearly 219,000 new cases of prostate cancer were diagnosed in the United States. With prostate cancer as the second leading cause of cancer death in American men, MR plays a vital role in determining which men are at serious risk. Siemens now offers a syngo solution to facilitate the detection of prostate cancer.
syngo Tissue 4D offers dynamic evaluation with quantification of tumour tissues in organs, such as the prostate and liver. This solution offers two evaluation workflows: standard and Pharmacokinetic modelling (PKM). PKM quantifies the contrast uptake and can be used for oncology workflow and follow-up studies. syngo Tissue 4D is easy to use and offers a fast and guided navigation through all workflow steps, including Motion Correction, Registration, Curve evaluation, Pre evaluation (PKM prep), Evaluation (PKM), Result, and Reporting.